DCT

3:09-cv-02445

Novo Nordisk Inc v. Mylan Pharma Inc

General
Filed
05/20/09
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (12/02/10)
Patent Owner
Operating Company (L)
Judge
Period
PO Win Rate
--
73%
Plaintiff